The Beauty Health Co. (SKIN) Stock Price, Quote & News

Latest News on SKIN

Mar 12, 2025, 10:09 PM EDT - 5 weeks ago

The Beauty Health Company (SKIN) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 4:05 PM EDT - 5 weeks ago

BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results

Dec 17, 2024, 4:30 PM EST - 4 months ago

BeautyHealth Appoints Stephen J. Fanning to Board of Directors

Dec 11, 2024, 8:00 AM EST - 4 months ago

BeautyHealth Releases 2024 Skintuition Report

Dec 6, 2024, 9:30 AM EST - 4 months ago

Glancy Prongay & Murray LLP Announces Investigation of The Beauty Health Company (SKIN) f/k/a Vesper Healthcare Acquisition Corp.

Nov 12, 2024, 9:00 PM EST - 5 months ago

The Beauty Health Company (SKIN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:05 PM EST - 5 months ago

BeautyHealth Reports Third Quarter 2024 Financial Results

Nov 8, 2024, 8:00 AM EST - 5 months ago

BeautyHealth to Report Third Quarter 2024 Financial Results on November 12, 2024

Oct 17, 2024, 3:28 PM EDT - 6 months ago

Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery's Annual Meeting (ASDS): Hydrafacial enhances the outcomes of non-ablative laser and IPL treatments

Oct 15, 2024, 4:10 PM EDT - 6 months ago

The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments

Oct 1, 2024, 8:00 AM EDT - 7 months ago

Hydrafacial Launches New Hydralock HA Booster with Clinically Proven Results

Aug 10, 2024, 9:00 AM EDT - 9 months ago

The Beauty Health Company Q2 2024 Earnings: Will It Ever Be Profitable?

Aug 9, 2024, 1:17 PM EDT - 9 months ago

The Beauty Health Company (SKIN) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 9 months ago

BeautyHealth Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 8:00 AM EDT - 9 months ago

BeautyHealth to Report Second Quarter 2024 Financial Results on August 8, 2024

May 13, 2024, 12:45 PM EDT - 1 year ago

The Beauty Health Company Q1 2024 Earnings: Sitting Pretty Or Turning Ugly?

May 9, 2024, 10:42 PM EDT - 1 year ago

The Beauty Health Company (SKIN) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:05 PM EDT - 1 year ago

BeautyHealth Reports First Quarter 2024 Financial Results

Apr 26, 2024, 8:00 AM EDT - 1 year ago

BeautyHealth to Report First Quarter 2024 Financial Results on May 9, 2024

Apr 9, 2024, 4:10 PM EDT - 1 year ago

BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

Mar 17, 2024, 9:00 AM EDT - 1 year ago

The Beauty Health Company: A Turnaround Post Earnings?

Mar 12, 2024, 10:56 PM EDT - 1 year ago

The Beauty Health Company (SKIN) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 4:10 PM EDT - 1 year ago

BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results

Mar 12, 2024, 4:05 PM EDT - 1 year ago

BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer

Feb 29, 2024, 4:06 PM EST - 1 year ago

BeautyHealth To Now Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

Feb 27, 2024, 4:05 PM EST - 1 year ago

BeautyHealth to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

Jan 16, 2024, 12:05 AM EST - 1 year ago

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

Jan 15, 2024, 5:00 AM EST - 1 year ago

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses of $100,000 to Contact the Firm

Jan 11, 2024, 1:30 PM EST - 1 year ago

BEAUTY HEALTH INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options

Jan 9, 2024, 7:00 AM EST - 1 year ago

FINAL DEADLINE THIS MONTH: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

Jan 8, 2024, 4:00 AM EST - 1 year ago

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

Jan 4, 2024, 11:00 AM EST - 1 year ago

BEAUTY HEALTH INVESTOR DEADLINE APPROACHING

Dec 29, 2023, 3:30 AM EST - 1 year ago

IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

Dec 22, 2023, 7:00 AM EST - 1 year ago

FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

Dec 21, 2023, 7:00 AM EST - 1 year ago

INVESTOR ACTION DEADLINE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

Dec 19, 2023, 5:30 AM EST - 1 year ago

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

Dec 11, 2023, 6:30 AM EST - 1 year ago

IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

Dec 6, 2023, 7:00 AM EST - 1 year ago

FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm

Dec 5, 2023, 5:35 PM EST - 1 year ago

SKIN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that The Beauty Health Company Investors with Substantial Losses Have Opportunity to Lead Case

Dec 5, 2023, 6:15 AM EST - 1 year ago

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses of $100,000 to Contact the Firm

Dec 4, 2023, 7:00 AM EST - 1 year ago

IMPORTANT DEADLINE NOTICE: The Schall Law Firm Reminds Investors in The Beauty Health Company with Losses In Excess of $100,000 to Contact the Firm

Dec 1, 2023, 6:30 AM EST - 1 year ago

Market Cap	105.93M
Revenue (ttm)	334.29M
Net Income (ttm)	-29.10M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-8.71%
Debt to Equity Ratio	0.00

Volume	564,700
Avg Vol	689,984
Day's Range	N/A - N/A
Shares Out	125.25M
Stochastic %K	5%
Beta	0.84
Analysts	Hold
Price Target	$1.49